Skip to main content
. Author manuscript; available in PMC: 2014 Sep 27.
Published in final edited form as: J Allergy Clin Immunol. 2013 May 31;132(1):170–181. doi: 10.1016/j.jaci.2013.04.048

Fig. 4. In vivo treatment with suppressive exosome-like nanovesicles inhibits established CS responses in actively sensitized mice.

Fig. 4

Ts Sup vs. control Sham Sup nanovesicles were injected i.p. at 24h of an ongoing CS response in actively sensitized and ear challenged mice. The Ts Sup exosomes suppressed CS at 48h and 72 wher eas the Sham Sup vesicles were non-inhibitory.